Cargando…
Inflammasomes as Targets for Adjuvants
Inflammasomes are an essential part of the innate immune system. They are necessary for the development of a healthy immune response against infectious diseases. Inflammasome activation leads to the secretion of pro-inflammatory cytokines such as IL-1β and IL-18, which stimulate the adaptive immune...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238254/ https://www.ncbi.nlm.nih.gov/pubmed/32235526 http://dx.doi.org/10.3390/pathogens9040252 |
_version_ | 1783536503725490176 |
---|---|
author | Ivanov, Konstantin Garanina, Ekaterina Rizvanov, Albert Khaiboullina, Svetlana |
author_facet | Ivanov, Konstantin Garanina, Ekaterina Rizvanov, Albert Khaiboullina, Svetlana |
author_sort | Ivanov, Konstantin |
collection | PubMed |
description | Inflammasomes are an essential part of the innate immune system. They are necessary for the development of a healthy immune response against infectious diseases. Inflammasome activation leads to the secretion of pro-inflammatory cytokines such as IL-1β and IL-18, which stimulate the adaptive immune system. Inflammasomes activators can be used as adjuvants to provide and maintain the strength of the immune response. This review is focused on the mechanisms of action and the effects of adjuvants on inflammasomes. The therapeutic and prophylaxis significance of inflammasomes in infectious diseases is also discussed. |
format | Online Article Text |
id | pubmed-7238254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72382542020-06-02 Inflammasomes as Targets for Adjuvants Ivanov, Konstantin Garanina, Ekaterina Rizvanov, Albert Khaiboullina, Svetlana Pathogens Review Inflammasomes are an essential part of the innate immune system. They are necessary for the development of a healthy immune response against infectious diseases. Inflammasome activation leads to the secretion of pro-inflammatory cytokines such as IL-1β and IL-18, which stimulate the adaptive immune system. Inflammasomes activators can be used as adjuvants to provide and maintain the strength of the immune response. This review is focused on the mechanisms of action and the effects of adjuvants on inflammasomes. The therapeutic and prophylaxis significance of inflammasomes in infectious diseases is also discussed. MDPI 2020-03-30 /pmc/articles/PMC7238254/ /pubmed/32235526 http://dx.doi.org/10.3390/pathogens9040252 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ivanov, Konstantin Garanina, Ekaterina Rizvanov, Albert Khaiboullina, Svetlana Inflammasomes as Targets for Adjuvants |
title | Inflammasomes as Targets for Adjuvants |
title_full | Inflammasomes as Targets for Adjuvants |
title_fullStr | Inflammasomes as Targets for Adjuvants |
title_full_unstemmed | Inflammasomes as Targets for Adjuvants |
title_short | Inflammasomes as Targets for Adjuvants |
title_sort | inflammasomes as targets for adjuvants |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238254/ https://www.ncbi.nlm.nih.gov/pubmed/32235526 http://dx.doi.org/10.3390/pathogens9040252 |
work_keys_str_mv | AT ivanovkonstantin inflammasomesastargetsforadjuvants AT garaninaekaterina inflammasomesastargetsforadjuvants AT rizvanovalbert inflammasomesastargetsforadjuvants AT khaiboullinasvetlana inflammasomesastargetsforadjuvants |